homoeriodictyol has been researched along with phlorhizin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Friedl, B; Geissler, K; Hans, J; Hoi, JK; Holik, AK; Krammer, GE; Ley, JP; Lieder, B; Liszt, K; Somoza, V | 1 |
2 other study(ies) available for homoeriodictyol and phlorhizin
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
The flavanone homoeriodictyol increases SGLT-1-mediated glucose uptake but decreases serotonin release in differentiated Caco-2 cells.
Topics: Adenocarcinoma; Biological Transport; Caco-2 Cells; Cell Differentiation; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Cyclic AMP; Extracellular Space; Flavones; Gene Expression; Glucose; Humans; Phlorhizin; Reverse Transcriptase Polymerase Chain Reaction; Serotonin; Signal Transduction; Sodium-Glucose Transporter 1 | 2017 |